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Background: Information on the comorbidity of mental health problems in prison
populations is scarce. The aim of the present study was to assess the prevalence of
comorbidities at intake to prison between three diagnostic groups: severe mental illnesses
(SMIs), personality disorders (PDs), and substance use disorders (SUDs). The co-
occurrence of those disorders in prison populations may require the integration of
differential treatment approaches and novel treatment trials.
Methods: A consecutive sample of N = 427 (229 male and 198 female) individuals
committed to imprisonment in Santiago de Chile was assessed with the Mini
Neuropsychiatric Interview and the Structured Clinical Interview for DSM-IV (module for
borderline personality disorders) on arrival at prison. Diagnoses were a priori grouped as
SMI including psychosis, bipolar disorder and major depression, PD including borderline
and antisocial PD and SUD including alcohol and drug abuse or dependence. Sex
stratified multivariate binary logistic regression analyses were conducted to assess
sociodemographic, criminal and treatment characteristics of individuals with at least
one diagnosis from each of the three diagnostic groups.
Results: The triad of SMI, PD, and SUD was present in n = 138 (32.3%; 95% IC: 28.0–
36.9) study participants, n = 105 (45.9%; 95% CI: 39.4–52.4) of the men and n = 33
(16.7%; 95% CI: 12.1–22.6) of the women. Among those with the disorder triad, n = 129
(30.2%; 95% CI: 26.0–34.8) had major depression, PD and SUD; n = 54 (12.6%; 95% CI:
9.8–16.2) had psychosis, PD and SUD. The disorder triad was more common in men
(OR = 4.86; 95% IC: 2.63–8.95), younger age (OR = 0.94; 95% CI: 0.91–0.97), and
participants with lower educational levels (OR = 1.69; 95% CI: 1.01–2.82). The disorder
triad was significantly associated with previous incarcerations (OR 2.60; 95% CI: 1.55–
4.34) and histories of psychiatric hospitalizations (OR 2.82; 95% CI: 1.27–6.28).
Discussion: The complex triad of disorders from different diagnostic groups is common
in prison populations, especially among young men. Successful treatment interventionsg August 2020 | Volume 11 | Article 8041
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Frontiers in Psychiatry | www.frontiersin.ormay have the potential to break a cycle of repeat institutionalization in prisons and
psychiatric institutions.Keywords: prison population, prevalence, severe mental illness (SMI), comorbid addictions, personality disorder
(PD), substance use disorder (SUD)INTRODUCTION
Over 11 million people are held in prisons throughout the world
at any given time (1). A range of studies including meta-analyses
established prevalence estimates for single psychiatric disorders
that were consistently higher than in the general populations (2).
The prevalence of psychosis was estimated to be 3.6% in male
and 3.9% in female prisoners, while the prevalence of major
depression was 10.2 and 14.1% respectively (3). High rates of
alcohol (24%) and drug use disorders (30–51%) were present in
prison populations on intake to the facility (4, 5). Personality
disorders (PDs) were reported to be common in prison
populations, with borderline personality disorders present in
approximately half of the population (6, 7). Antisocial
personality disorder was present in more than half of the
young male prison population and in 90% of those with
childhood onset conduct disorder (8).
However, in order to better understand the treatment and
care needs, it is necessary to assess the co-occurrence of several
mental health and substance use problems in prison populations.
Comorbidity has been reported in different ways for differential
purposes: First, it has been reported as the number of disorders
co-occurring and covered by the given instrument used in a
study (9–11), which serves the purpose of identifying groups
with multiple disorders, polymorph psychopathology, and
unfavorable outcomes. However, assessing the quantity of
diagnoses has the disadvantage that it does not distinguish
between the types of comorbidity. For example, two comorbid
anxiety disorders may be less complex to treat and less relevant
than comorbid major depression with psychotic symptoms and
illicit drug dependence. A second way to approach comorbidity
among prison populations is to a priori group disorders based on
similarity in treatment needs or psychopathology and assess co-
occurrence across those groups, i.e. severe mental illness (SMI)
and substance use disorders (SUDs) (12) or SUD and other
disorders (13) or SUD, internalizing disorders and behavioral
disorders (14). This approach generates prevalence estimates for
specific combinations of disorders that are potentially relevant
for clinical management and are comparable between settings. A
third approach to report comorbidity is statistically driven,
generating groups derived from the data, such as latent class
analysis of diagnoses (15). This allows further understanding of
the complexity of psychopathology and how the diagnoses relate
to each other. Four groups were derived from latent class
analyses of diagnoses in prison populations, including no
comorbidities, internalizing disorders, externalizing disorders,
and one group with multiple co-occurring disorders representing
11% of the prisoner population, which may pose particular
clinical challenges and face scarcity of evidence for treatment
interventions (15).g 2In all, the most pragmatic and clinically useful approach to
address comorbidity may be to a priori aggregate single
diagnoses in diagnostic groups that require similar treatment
(14, 16): SMIs including major depression and psychosis
regularly require psychiatric evaluation and medication. PDs
often require psychotherapies such as dialectic behavioral
therapy and SUD motivational interviewing, relapse
prevention, and for some people, temporarily controlling the
access to substances. Especially, the co-occurrence of disorders
across those diagnostic groups may pose additional challenges
for treatment planning and integration (17) and for prognosis,
whereas comorbid disorders within specific diagnostic groups
can often be treated using one single approach and thus are less
relevant for treatment planning. Focusing among the axis one
disorders on the severe disorders and treating them as a group
is pragmatic and in line with international research on
interventions for co-occurring mental health and substance use
disorders in general (18, 19) and in prison populations (16).
Individuals with antisocial PD may differ from those with
borderline PD regarding the criminal profiles: whereas people
with antisocial PD tend to show more instrumental violence,
people with borderline PD commit more often emotional
violence as a result from impulsivity (20). Nevertheless,
grouping several personality disorders for the assessment of
clinically relevant comorbidity as separate from substance use
disorders is common in research and practice (21). The aim of
the present study was to assess the prevalence of co-occurring
disorders across the three a priori defined diagnostic groups SMI,
PD, and SUD in prison populations. For those with the complex
triad of disorders from each of the diagnostic groups, we aimed
to assess socio-demographic and criminal characteristics.METHODS
Sample
Study participants were recruited from consecutively admitted
prison populations in the three remand prison facilities serving
the metropolitan region of Santiago de Chile: Santiago Uno,
which serves as a central facility for admissions of male prisoners
and Centro Penitenciario Feminino (CPF) San Joaquıń and CPF
San Miguel serving female prisoners. The interviews were usually
conducted within the first week of imprisonment (median 5 days;
mean 7.7 days after imprisonment). There were 470 potentially
eligible individuals for the study. Seven were excluded due to
mental or psychological incapacities to participate. Thirty
rejected participation; six prematurely ended the interview and
were excluded from analysis; data of 427 participants were used
in the analyses. The rejection rate was 7.0%.August 2020 | Volume 11 | Article 804
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Age and sex were assessed using structured questions.
Relationship status indicated whether respondents were living
alone or with somebody else. The highest educational level was
first classified according to the International Standard
Classification of Education (ISCED) (22) and then divided into
primary or lower (ISCED levels 0 and 1) versus secondary or
higher (ISCED levels 2–6) educational levels. Employment status
had two categories indicating working for income and not
working for income (unemployed, house keeping). The type of
criminal offense was classified into categories: property offense,
violent crime, drug use or trafficking, possession of firearm,
sexual offense, or others. The number of previous psychiatric
hospitalizations and previous incarcerations was recorded and
coded as present or absent. All information was derived from the
interviews. We did not have access to the health or criminal files
of the study participants.
The Mini-International Neuropsychiatric Interview (MINI)
was used in the Spanish version to assess mental health and
substance use disorders (23) to classify axis I mental disorders
and antisocial personality disorder according to the fourth
version of the Diagnostic and Statistical Manual of Mental
Disorders (DSM-IV). We further used the module for
borderline personality disorder of the Structured Clinical
Interview for DSM-IV (SCID-II).
Procedure
All female intakes to the prison system of the metropolitan region
in Santiago, Chile and every third man on the daily intake lists were
approached for study participation. Potential participants were first
approached by the prison guard on call assisting in the logistics of
the study and when available brought to the interview area of the
institution for information on the study. We aimed to recruit 200
participants of each gender. Interviews were conducted by four
clinical psychologists and a trained nurse and supervised by a senior
consultant psychiatrist in using the instruments. In order to
improve inter-rater concordance, pairs of interviewers conducted
the first 20 interviews together. The interviewers alternated the lead
of the interview and discussed points of discordance. The interviews
lasted for 45–60 min and were held in a separate room of the prison
to ensure confidentiality. The data collection took place between
February 2013 and September 2013. There was a complete
discussion of the study with potential participants, and all
participants provided written informed consent after this
discussion. The authors assert that all procedures contributing to
this work comply with the ethical standards of the relevant national
and institutional committees on human experimentation and with
the Helsinki Declaration of 1975, as revised in 2008. The study was
approved by the Ethics Review Board of the University of Chile
(Acta de Aprobación 01 from 25.01.2012) and by the Ministry of
Justice of the Republic of Chile (reference: Subsecretaria de Justicia
15.03.2012). For further details on the study procedures see (7).
Analyses
We estimated prevalence rates with 95% Confidence Intervals
(95% CI) for the diagnostic groups severe mental illnesses,Frontiers in Psychiatry | www.frontiersin.org 3personality disorders, substance use disorders, and for different
types of comorbidities. Current major depression, bipolar
disorders and/or psychotic disorders were aggregated as the
diagnostic group of SMI. The decision to manage SMI as one
group for the assessment of comorbidity was not based on
homogeneity in the psychopathology, but the consideration
that either psychosis or major depression co-occurring with
SUD and/or PD can complicate clinical management and
prognosis. Borderline personality disorder and/or antisocial
personality disorder was aggregated as the diagnostic group of
PD. Drug and/or alcohol abuse and dependence were aggregated
in the diagnostic group SUD. The grouping of disorders and
juxtaposition with others was a priori and treatment oriented,
not based on statistical measures and not derived from the data.
We assessed the prevalence of dual disorders with at least one
disorder from two diagnostic groups, irrespectively of whether a
disorder from the third group was present or not. We also assessed
the prevalence of having at least one disorder from each of the three
groups. For the co-occurring disorder triad of SMI, PD, and SUD,
we further explored the risk profile, separately for male and female
prisoners. First, sociodemographic and criminal characteristics as
well as indicators of previous institutionalization were described
among prisoners with and without the comorbid triad, using chi-
square tests and t-tests to test for significance. Secondly, a
multivariate logistic regression model was used to examine which
covariates predicted the presence of the comorbid disorder triad.
Strong correlation between explanatory variables may cause biased
regression coefficients; therefore, we tested for multicollinearity
with the variance inflation factor (<10) and tolerance scores (>0.1).
As the criminal offense of ‘drug use and trafficking’ showed high
multicollinearity in the female subsample, we dropped this variable
from the model run on the female subsample.
All statistical analyses were performed with Stata, version 13.RESULTS
The triad of SMI, PD, and SUD was present in n = 138 (32.3%) of
the total prison population, in n = 105 (45.9%) of the male, and
n = 33 (16.7%) of the female study participants. The larger part of
those individuals n = 129 (30.2%) had MD, PD, and SUD; the
smaller part n = 54 (12.6%) had psychosis, PD, and SUD. Dual
disorders from any two of the three diagnostic groups
(irrespective of the presence of a disorder from the third
group) were present in about 40%, and a single disorder from
any of the three categories was present in more than half of the
prison population. Dual disorders of severe mental illness co-
occurring with PD and SMI co-occurring with SUD were present
in n = 178 (41.7%) and n = 168 (39.2%) respectively. Co-
occurring personality disorder and substance use disorder were
present in n = 179 (41.9%; Table 1). Prevalence rates of dual
disorders and disorder triads are also shown separately for male
and female prisoners. Those rates were in general higher in men
than in women.
Table 2 shows descriptive statistics and bivariate analyses for
prison populations with the triad of SMI, PD, and SUDAugust 2020 | Volume 11 | Article 804
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are shown for the total population and separately for male and
female prisoners. Prison population with the disorder triad were
younger, less likely to be living with a partner, more likely to be
charged for any violent crime, and less likely to be charged for
any drug associated crime. Furthermore, individuals with the
disorder triad had more likely been previously imprisoned and
received psychiatric hospital treatment. The differences in age,
previous imprisonment, and psychiatric hospitalization were
observed in both male and female subsamples. The differences
in educational level, charges for violent crime, and drug
associated crime were only seen in the female population,
whereas men with the disorder triad were more likely to be
unemployed prior to imprisonment (Table 2).
In the regression model testing, the link with sociodemographic
variables for the whole sample, male sex (OR = 4.86; 95% IC: 2.63–
8.95; p < 0.001), young age (OR = 0.94; 95% CI: 0.91–0.97; p <
0.001), and lower educational level (OR = 1.69; 95% CI: 1.01–2.82; p
< 0.05) was identified as risk factors for the disorder triad (Table 3).
Furthermore, the disorder triad was associated with previous
imprisonment (OR 2.60; 95% CI: 1.55–4.34; p < 0.001) and
previous psychiatric hospitalization (OR 2.82; 95% CI: 1.27–6.28;
p < 0.001) indicating an increased risk of repeat institutionalization
in this population (Table 3).Frontiers in Psychiatry | www.frontiersin.org 4DISCUSSION
About one third of our sample presented a disorder triad of severe
mental disorder, personality disorder, and addiction at the moment
of intake to prison in Santiago, Chile. This triad was more common
among young men with lower educational levels and it was
associated with indicators of previous institutionalization.
In concordance with previous findings, our results indicate that
comorbid mental health and substance use disorders are common
among prisoners. High rates of comorbidity have been shown for
borderline personality disorder with both major depression (82%)
and with substance dependence (73%) in prison populations (24).
Prisoners with SMI also had high rates of SUD (12, 13, 25). For
female prison populations with substance dependence, the
prevalence of major depression was reported to be 62% in Mexico
(26). About half of the prisoner populations with substance use
disorders were reported to also have depression and/or anxiety
disorders (13, 27). And vice versa, rates of substance use disorders
were reported to be above 75% among prisoner populations with
depression and anxiety disorders (28, 29). In contrast to our study,
others evaluated the prevalence data over the lifespan. The lifetime
prevalenceof substanceusedisorders amongprisonerswith lifetime
prevalence of psychosis may be up to 90% (30). Co-occurring
mental disorders and substance use disorder were reported forTABLE 1 | Comorbidities between different groups of disorders: 1. Severe mental disorders (SMI) including psychosis, major depression (MD) and bipolar disorders; 2.
Personality disorders (PD) including borderline personality disorders (BPD) and antisocial personality disorders (APD); 3. Substance use disorders (SUD), including
alcohol and drug use disorders.
Groups of disorders Total(n = 427) Male(n = 229) Female(n = 198)
n % 95% CI n % 95% CI n % 95% CI
SMI 251 58.8 54.0–63.4 143 62.4 55.9-68.5 108 54.4 47.5-61.4
Psychosis 68 15.9 12.7-19.7 51 22.3 17.3-28.2 17 8.6 5.4-13.4
MD 233 54.6 49.8-59.3 137 59.8 53.3-66.0 96 48.5 41.5-55.5
PD 231 54.1 49.3-58.8 163 71.2 64.9-76.7 68 34.3 28.0-41.3
BPD 216 50.6 45.7–55.3 154 67.2 61.1–73.8 62 31.3 24.8–38.4
APD 126 29.5 25.3–34.0 91 41.9 35.4–48.0 30 15.2 10.1–20.2
SUD 237 55.5 50.7-60.2 173 75.6 69.5-80.7 64 32.3 26.1-39.2
Comorbidities between groups of disorders
SMI and PD 178 41.7 37.1–46.4 124 54.1 47.6–60.5 54 27.3 21.5–34.0
Psychosis and PD 62 14.5 11.5–18.2 49 21.4 16.5–27.2 13 6.6 3.8–11.0
MD and PD 167 39.1 34.6–43.8 119 52.0 45.4–58.4 48 24.2 18.7–30.8
SMI and SUD 168 39.3 34.8–44.1 120 52.4 45.9–58.8 48 24.2 18.7–30.8
Psychosis and SUD 59 13.8 10.8–17.4 46 20.1 15.4–25.8 13 6.6 3.8–11.0
MD and SUD 153 35.8 31.4–40.5 114 49.8 43.3–56.3 39 19.7 14.7–25.9
PD and SUD 179 41.9 37.3–46.7 138 60.3 53.7–66.4 41 20.7 15.6–27.0
BPD and SUD 170 39.8 35.3–44.6 130 56.8 50.2–63.1 40 20.2 15.1–26.4
APD and SUD 111 26.0 22.0–30.4 91 39.7 33.6–46.2 20 10.1 6.6–15.2
SMI, PD and SUD 138 32.3 28.0–36.9 105 45.9 39.4–52.4 33 16.7 12.1–22.6
Psychosis, PD and SUD 54 12.6 9.8–16.2 44 19.2 14.6–24.9 10 5.1 2.7–9.2
Psychosis, BPD and SUD 54 12.6 9.8–16.2 44 19.2 14.6–24.9 10 5.1 2.7–9.2
Psychosis, APD and SUD 38 8.9 6.5–12.0 33 14.4 10.4–19.6 5 2.5 1.0–6.0
MD, PD and SUD 129 30.2 26.0–34.8 100 43.7 37.3–50.2 29 14.6 10.3–20.3
MD, BPD and SUD 125 29.3 25.1–33.8 97 42.4 36.1–48.9 28 14.1 9.9–19.8
MD, APD and SUD 86 20.1 16.6–24.2 72 31.4 25.7–37.8 14 7.1 4.2–11.6August 2020 | Volume 11 |First, prevalence rates of dual disorders are reported considering three different combinations out of the three disorder groups (SMI and PD; SMI and SUD; PD and SUD). Dual disorders
are considered prevalent irrespective of whether any disorder from the third group is present or not. Secondly, those with the disorder triad with at least one disorder from each of the three
groups are reported. Under the prevalence of dual and triple disorders from different groups, the combination for specific (mutually non-exclusive) diagnoses with any disorder from a
different group is reported using line indents.Article 804
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Australia (29), and 21% in Italy (32), lower than in this study.
Forensic populations with the triad of mental disorders, SUD,
and antisocial personality disorder may be responsible for more
serious and frequent offending (33). Our study showed that
people with diagnostic triads in prisons have histories of repeat
institutionalizations in psychiatric care and penal justice systems.
In South American societies, the removal of psychiatric beds was
associated with an increase of prison population rates (34). The
crisis in acute psychiatric care may have caused a shift of
responsibility to care for people with complex diagnostic triads
from psychiatric settings to criminal justice systems. Repeat
imprisonments and psychiatric hospitalization in the past may
indicate increased risk for future episodes of institutionalization.
The prevalence of a comorbid triad between internalizing
disorders (mood and anxiety disorders), substance use disorders,
and behavioral disorders (conduct and oppositional defiant
disorder if ≤17 years old and antisocial personality disorder if ≥
18years old)hadbeen reported for juvenileoffenders (14).The triad
was present in11%of the adolescentmenand14%of the adolescent
women in juvenile detention. The three diagnostic groups
juxtaposed in our study usually require different treatment
approaches: SMIs often need repeat psychiatric evaluations and
medication (18). PDsmay respond to dialectic behavioral therapies
and often require long term psychotherapy (35). SUDs are usually
treated with relapse prevention, motivational and contingency
therapies, medication, and often social and occupational careFrontiers in Psychiatry | www.frontiersin.org 5(36). Active substance use and emotional dysregulation can
interfere with any of the treatments. All of the conditions need
informant histories and family involvement. Transdiagnostic
treatments focusing on core difficulties such as emotional
regulation have been proposed (37), and new communication
technologies may improve the access to those treatments (38).
How to successfully integrate the treatment needs for people with
complex comorbidity within the prison context is unresolved.
However, imprisonment constitutes an opportunity to offer
treatments during a period in life with limited or reduced access
to substances to populations that are difficult to reach with
outpatient treatment offers in the community. This window of
opportunity is currently underused in most systems. Clearly, it is
not sufficient to transfer evidence fromclinical settings to this highly
comorbid population. New intervention trials are needed to test
efficacy in this population and setting.
Strengths and Limitations
To our knowledge this is the first study describing the prevalence
of a triad between different clinically relevant groups of disorders
in prison populations of Latin America. It was sufficiently powered
to assess the effect of a range of sociodemographic and criminal
risk factors as well as histories of previous institutionalizations
on the outcome. This study has also several limitations. The
interview schedule of our study did not include the assessment
of neurodevelopmental disorders such as attention deficit/
hyperactivity disorder, autism spectrum disorders, and intellectualTABLE 2 | Sociodemographic and criminal characteristics of male and female prisoners with and without the comorbid triad of mental disorders: severe mental illnesses
(SMIs), personality disorders (PDs) and substance use disorder (SUD).














n % n % n % n % n % n %
Age, mean (SD)a 34.0 (12.1) 26.6 (7.9) *** 33.0 (13.5) 26.4 (7.83) *** 34.7 (11.1) 27.2 (8.2) ***
Educational level
Primary or lower 133 46.0 71 51.5 42 33.9 44 41.9 91 55.1 27 81.8
Secondary or higher 156 54.0 67 48.5 82 66.1 61 58.1 74 44.9 6 18.2 **
Employment status
Yes 230 79.6 101 73.2 112 90.3 83 79.0 118 71.5 18 54.6
No 59 20.4 37 26.8 12 9.7 22 21.0 * 47 28.5 15 45.5
Relationship status
Living alone 147 50.9 85 61.6 61 49.2 65 61.9 86 52.1 20 60.6
Living with partner 142 49.1 53 38.4 * 63 50.8 40 38.1 79 47.9 13 39.4
Offense categoryb
Property 66 22.8 40 29.0 36 29.0 29 27.6 30 18.2 11 33.3
Violence 68 23.5 59 42.8 *** 46 37.1 48 45.7 22 13.3 11 33.3 **
Drug 128 44.3 22 15.9 *** 18 14.5 13 12.4 110 66.7 9 27.3 ***
Firearm 5 1.7 4 2.9 3 2.4 4 3.8 2 1.21 0 0.0
Sexual 9 3.1 5 3.6 9 7.3 5 4.8 0 0.0 0 0.0
Previous imprisonment
No 162 56.1 60 43.5 81 65.3 52 49.5 81 49.1 8 24.2
Yes 127 43.9 78 56.5 * 43 34.7 53 50.5 * 84 50.9 25 75.8 **
Previous psychiatric hospitalization
No 272 94.1 118 85.5 119 96.0 91 86.7 153 92.7 27 81.8
Yes 17 5.9 20 14.5 ** 5 4.0 14 13.3 * 12 7.3 6 19.2 *August 2020 | Volume 11 | Article 8*p < 0.05; **p < 0.01; ***p < 0.001.
aVariable encounters 10 missing cases.
bCategories are not mutually exclusive.04
Mundt and Baranyi The Unhappy Mental Health Triaddisability, whichmay relate to other mental disorders and disruptive
behaviors in prison populations (39). It was conducted in Chile, and
the findings may not be applicable to other high-income economies.
This limitation may apply particularly to women since the
prevalence of SUD was considerably lower than in most Western
high-income countries (4).
Conclusions for Research, Practice,
and Policy
Thecomplexityanddifficulty to treat comorbidityofSMI,SUD,and
PDarepresent in about one out of threepeople upon imprisonment
inChile. It is especially frequent in youngmen and individuals with
lower educational levels. Routine screening for mental disorders
should include those three disorder groups to identify individuals
with complex treatmentneeds and toconnect themwithpsychiatric
services during and after imprisonment. Treatment trials
specifically targeting people with those complex disorder triads
are needed inside prison contexts as well as in psychiatric and
community settings. Continuous caremodels need to be developed
involving interdisciplinary and interinstitutional collaborations to
break the cycle of repeat institutionalizations in prisons and
in hospitals.
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Sex
Male 4.86 2.63–8.95*** N/A N/A
Female ref
Age 0.94 0.91–0.97*** 0.94 0.91–0.97*** 0.92 0.87–0.98**
Education
Primary or lower 1.69 1.01–2.82* 1.23 0.65–2.32 3.14 1.15–8.56*
Secondary or higher ref ref ref
Employment status
Yes ref ref ref
No 1.63 0.89–2.99 1.91 0.81–4.50 1.27 0.50–3.17
Relationship status
Living alone ref ref ref
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Firearm 1.42 0.26–7.94 2.10 0.32–14.01 b
Sexual 1.17 0.24–5.73 1.48 0.28–7.86 b
Previous imprisonment
No ref ref ref
Yes 2.60 1.55–4.34*** 2.50 1.34–4.68** 4.35 1.58–12.00**
Previous psychiatric hospitalization
No ref ref ref
Yes 2.82 1.27–6.28*** 4.65 1.40–15.38* 1.34 0.38–4.73August 2020 | Volume 11*p < 0.05; **p < 0.01; ***p < 0.001.
aDropped because of multicollinearity.
bDropped because no case was present.| Article 804
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